Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, SARS-CoV-2 test, Swelling
Clinical narrative: Myocarditis; required catheterization procedure to check for blockages; Major swelling of heart muscle; Major swelling of heart muscle; Difficulty breathing; major STEMI heart attack; major STEMI heart attack; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Sep2021 12:00 (Batch/Lot number: unknown) at the age of 51 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "no" (unspecified if ongoing), notes: other medical history no. There were no concomitant medications. Vaccination history included: Bnt162b2 (Previous dose details , Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False, Prev dose lot unknown=True, Prev dose lot unknown reason=Not available/provided to reporter at the time of report completion, Prev dose administrationdate=23Aug2021, Prev dose administration time=12:00 PM, Prev dose dose number=1, Prev dose vaccine location=Left arm), administration date: 23Aug2021, when the patient was 51 years old, for COVID-19 Immunization. The following information was reported: MYOCARDITIS (hospitalization, disability, life threatening) with onset 16Sep2021 10:00, outcome "recovered with sequelae", described as "Myocarditis"; CATHETERISATION CARDIAC (hospitalization, disability, life threatening) with onset 16Sep2021 10:00, outcome "recovered with sequelae", described as "required catheterization procedure to check for blockages"; CARDIAC DISORDER (hospitalization, disability, life threatening), SWELLING (hospitalization, disability, life threatening) all with onset 16Sep2021 10:00, outcome "recovered with sequelae" and all described as "Major swelling of heart muscle"; DYSPNOEA (hospitalization, disability, life threatening) with onset 16Sep2021 10:00, outcome "recovered with sequelae", described as "Difficulty breathing"; ACUTE MYOCARDIAL INFARCTION (hospitalization, disability, life threatening), MYOCARDIAL INFARCTION (hospitalization, disability, life threatening) all with onset 16Sep2021 10:00, outcome "recovered with sequelae" and all described as "major STEMI heart attack". The patient was hospitalized for myocarditis, catheterisation cardiac, cardiac disorder, swelling, dyspnoea, acute myocardial infarction, myocardial infarction (hospitalization duration: 2 day(s)). The events "myocarditis", "required catheterization procedure to check for blockages", "major swelling of heart muscle", "major swelling of heart muscle", "difficulty breathing", "major stemi heart attack" and "major stemi heart attack" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (16Sep2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of myocarditis, catheterisation cardiac, cardiac disorder, swelling, dyspnoea, acute myocardial infarction, myocardial infarction. Clinical course: Anti-inflammatory and other drugs were given as treatment for adverse events. The patient recovered from events with lasting effects. The patient did not receive other vaccine within four weeks prior to COVID vaccine. The patient did not receive other medications in two weeks prior to COVID vaccine. The patient did not have COVID prior vaccination. The patient had no known allergies. Adverse events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  The lot number for bnt162b2 was not provided and will be requested during follow up.